Optinose Announces Conference Call Dates
Optinose, a dedicated pharmaceutical firm specializing in ENT and allergy treatments, has excitedly revealed its plans to disclose financial results for the fourth quarter and the complete year of 2024. This event is scheduled for a Thursday morning event where the leadership team will provide essential information to stakeholders.
Details of the Financial Report
The anticipated financial results report will take place on a Thursday morning, just before the market opens, providing investors with timely insights into the company’s performance. This announcement signifies an important benchmark for the firm as it shares its progress and developments over the past year.
What to Expect?
During the conference call, which kicks off at 8:00 a.m. Eastern Time, participants will hear extensive details regarding the financial outcomes and corporate updates straight from the executive team. This is an excellent opportunity for analysts and investors to gain a deeper understanding of Optinose's accomplishments and future directions.
How to Join the Call
For those wishing to engage in the call, Optinose has provided easy access. The conference call will be available via webcast on the company's Investor Relations website. Additionally, participants looking to join by phone should be aware that advance registration is required. This will allow for streamlined participation, with confirmation details sent directly to attendees.
Replay Availability
After the call, a replay will be accessible on the company's official platform for an entire 60 days. This allows anyone who couldn’t attend the live event to catch up on critical updates and insights shared during the discussion.
About Optinose
Optinose is making significant strides as a specialty pharmaceutical company aimed at meeting the healthcare demands of patients receiving treatment from specialists in ENT and allergy fields. The innovative approaches they have developed reflect in their product offerings and engagement with medical professionals.
Investor Relations Contact
For inquiries or further information about the financial results announcement, investors can reach out to Jonathan Neely, whose contact details are available for direct communication. By contacting him, interested parties can gain tailored insights or clarifications on any specific issues.
Frequently Asked Questions
When will Optinose report its financial results?
Optinose will report its financial results for the fourth quarter and full year of 2024 on March 20, 2025.
How can I listen to the conference call?
The conference call can be listened to via a live webcast on the Optinose Investor Relations website.
What time does the conference call start?
The conference call is scheduled to start at 8:00 a.m. Eastern Time.
Will there be a replay of the conference call?
Yes, a replay of the conference call will be available on the company’s website for 60 days following the event.
Who can I contact for more information about Optinose?
For more inquiries, you can contact Jonathan Neely at the phone number provided in the investor relations section.
